Schmidt, Tobias T.
Tyer, Carly
Rughani, Preeyesh
Haggblom, Candy
Jones, Jeffrey R. http://orcid.org/0000-0002-7570-2571
Dai, Xiaoguang
Frazer, Kelly A.
Gage, Fred H. http://orcid.org/0000-0002-0938-4106
Juul, Sissel http://orcid.org/0000-0002-0315-4449
Hickey, Scott http://orcid.org/0009-0009-0785-677X
Karlseder, Jan http://orcid.org/0000-0001-7433-9750
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA227934, P30CA014195, CA234047)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM142173)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG0773424)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
American Heart Association (19PABH134610000)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
European Molecular Biology Organization (ALTF 668-2019)
Article History
Received: 25 October 2023
Accepted: 15 May 2024
First Online: 18 June 2024
Competing interests
: C.H., J.R.J., K.A.F., F.H.G., and J.K. declare that they have no competing interests. T.T.S. has received travel funds to speak at events hosted by Oxford Nanopore Technologies. C.T., P.R., X.D., S.J., and S.H. are employees of Oxford Nanopore Technologies, Inc. and are stock or stock option holders in Oxford Nanopore Technologies plc. C.T., P.R., X.D., and S.H. are named as inventors on a patent application covering aspects of this work filed by Oxford Nanopore Technologies plc. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.